244 related articles for article (PubMed ID: 1471743)
1. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
[TBL] [Abstract][Full Text] [Related]
2. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
[TBL] [Abstract][Full Text] [Related]
3. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.
Charoenvit Y; Collins WE; Jones TR; Millet P; Yuan L; Campbell GH; Beaudoin RL; Broderson JR; Hoffman SL
Science; 1991 Feb; 251(4994):668-71. PubMed ID: 1704150
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibody to the variant repeat of the circumsporozoite protein of Plasmodium vivax in Peru.
Franke ED; Lucas CM; San Roman E; Wirtz RA
Am J Trop Med Hyg; 1992 Jun; 46(6):708-10. PubMed ID: 1621895
[TBL] [Abstract][Full Text] [Related]
5. Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax.
Cochrane AH; Nardin EH; de Arruda M; Maracic M; Clavijo P; Collins WE; Nussenzweig RS
Am J Trop Med Hyg; 1990 Nov; 43(5):446-51. PubMed ID: 2122747
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans.
Franke ED; Lucas CM; Chauca G; Wirtz RA; Hinostroza S
Am J Trop Med Hyg; 1992 Mar; 46(3):320-6. PubMed ID: 1373042
[TBL] [Abstract][Full Text] [Related]
7. Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.
Arévalo-Herrera M; Roggero MA; Gonzalez JM; Vergara J; Corradin G; López JA; Herrera S
Ann Trop Med Parasitol; 1998 Jul; 92(5):539-51. PubMed ID: 9797827
[TBL] [Abstract][Full Text] [Related]
8. Antibody response of humans to the circumsporozoite protein of Plasmodium vivax.
Franke ED; Lucas CM; San Roman E
Infect Immun; 1991 Aug; 59(8):2836-8. PubMed ID: 1855998
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax.
Millet P; Chizzolini C; Wirtz RA; Bathurst I; Broderson JR; Campbell GH; Collins WE
Eur J Immunol; 1992 Feb; 22(2):519-24. PubMed ID: 1371470
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to the circumsporozoite protein of Plasmodium vivax in Madagascar.
Migot F; Millet P; Chougnet C; Lepers JP; Deloron P
Am J Trop Med Hyg; 1993 Apr; 48(4):524-9. PubMed ID: 7683178
[TBL] [Abstract][Full Text] [Related]
12. Fine epitope specificity of antibodies to region II of the Plasmodium vivax circumsporozoite protein correlates with ability to bind recombinant protein and sporozoites.
Bilsborough J; Baumgart K; Bathurst I; Barr P; Good MF
Acta Trop; 1997 May; 65(2):59-80. PubMed ID: 9164601
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to the repeat epitope of the circumsporozoite protein of Plasmodium vivax in San Luis Potosi, Mexico.
Mota J; Coreño O; Cochrane AH; Ramos C
Arch Med Res; 1996; 27(2):233-6. PubMed ID: 8696070
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of antibodies to repetitive domains of Plasmodium vivax circumsporozoite protein in United Arab Emirates children.
Abu-Zeid YA; Alwash R; Shaheen HM; Bin-Othman SA; Lukic ML; Amiri KM; Charoenvit Y
Trans R Soc Trop Med Hyg; 2002; 96(5):560-4. PubMed ID: 12474490
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
Castellanos A; Arévalo-Herrera M; Restrepo N; Gulloso L; Corradin G; Herrera S
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):411-6. PubMed ID: 17568948
[TBL] [Abstract][Full Text] [Related]
17. Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.
Herrera S; Bonelo A; Perlaza BL; Valencia AZ; Cifuentes C; Hurtado S; Quintero G; López JA; Corradin G; Arévalo-Herrera M
Int J Parasitol; 2004 Dec; 34(13-14):1535-46. PubMed ID: 15582530
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
19. Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.
Shabani SH; Zakeri S; Salmanian AH; Amani J; Mehrizi AA; Snounou G; Nosten F; Andolina C; Mourtazavi Y; Djadid ND
Mol Immunol; 2017 Oct; 90():158-171. PubMed ID: 28800475
[TBL] [Abstract][Full Text] [Related]
20. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka.
Mendis C; Del Giudice G; Gamage-Mendis AC; Tougne C; Pessi A; Weerasinghe S; Carter R; Mendis KN
Parasite Immunol; 1992 Jan; 14(1):75-86. PubMed ID: 1557232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
